Choudhari Drug Distributors Profile
Key Indicators
- Authorised Capital ₹ 0.90 M
as on 22-06-2024
- Paid Up Capital ₹ 0.60 M
as on 22-06-2024
- Company Age 12 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 15.00 M
as on 22-06-2024
- Satisfied Charges ₹ 5.00 M
as on 22-06-2024
- Revenue -65.53%
(FY 2021)
- Profit -266.32%
(FY 2021)
- Ebitda -1653.45%
(FY 2021)
- Net Worth -540.83%
(FY 2021)
- Total Assets -24.85%
(FY 2021)
About Choudhari Drug Distributors
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.90 M and a paid-up capital of Rs 0.60 M.
The company currently has active open charges totaling ₹1.50 Cr. The company has closed loans amounting to ₹5.00 M, as per Ministry of Corporate Affairs (MCA) records.
Poonam Choudhari and Rajendra Choudhari serve as directors at the Company.
- CIN/LLPIN
U24132KA2011PTC061675
- Company No.
061675
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Dec 2011
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Belgaum, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Choudhari Drug Distributors?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Poonam Choudhari  | Director | 15-Dec-2011 | Current |
| Rajendra Choudhari | Director | 15-Dec-2011 | Current |
Financial Performance and Corporate Structure Insights of Choudhari Drug Distributors.
Choudhari Drug Distributors Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 65.53% decrease. The company also saw a substantial fall in profitability, with a 266.32% decrease in profit. The company's net worth observed a substantial decline by a decrease of 540.83%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Choudhari Drug Distributors?
In 2021, Choudhari Drug Distributors had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Mar 2017 | ₹1.50 Cr | Open |
Cosmos Co-Operative Bank Ltd Creation Date: 09 Jun 2012 | ₹5.00 M | Satisfied |
How Many Employees Work at Choudhari Drug Distributors?
Unlock and access historical data on people associated with Choudhari Drug Distributors, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Choudhari Drug Distributors, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Choudhari Drug Distributors's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
